M R Jacobs

Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group

Scott F. Dowell, Jay C. Butler, G. Scott Giebink et al. · The Pediatric Infectious Disease Journal · 1999 · 508 citations

Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media

Ron Dagan, CANDICE E. JOHNSON, Samuel E. McLinn et al. · The Pediatric Infectious Disease Journal · 2000 · 177 citations

Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin

S C Aronoff, M R Jacobs, S Johenning et al. · Antimicrobial Agents and Chemotherapy · 1984 · 123 citations

Pharmacotherapy, Antimicrobial Chemotherapy, Antibiotic Resistance +19

Pneumococcal Conjugate Vaccine Serotypes of<i>Streptococcus pneumoniae</i>Isolates and the Antimicrobial Susceptibility of Such Isolates in Children with Otitis Media

Moses Joloba, Anne Windau, Saralee Bajaksouzian et al. · Clinical Infectious Diseases · 2001 · 104 citations · Full text

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli

M R Jacobs, S C Aronoff, S Johenning et al. · Antimicrobial Agents and Chemotherapy · 1986 · 95 citations

Beta-lactamase Inhibitors, Ytr 830, Antimicrobial Susceptibility +15